Sponsors
Blog
Chairman, GDS International
Sales and the 'Talent Magnet'
A lot is written about being a ‘Talent Magnet’, either as a company, or as President. It’s all good practice – listen, mentor, reward, provide clear goals and career maps. Good practice for the employer, but what about the employee?25 May 2011
White Papers
Focus Area: Drug Discovery
Biomarkers - main drivers of innovation
By BIOCRATES Life Sciences AG. Biomarkers are rapidly becoming the main drivers of innovation in the 21st century. Because they improve the potential to tailor treatment to the specific needs of individual patients, they are a critical prerequisite to personalized medicine.
Optimizing your laboratory assets
GE Healthcare’s Matt Sawtell looks at the tools pharmaceutical companies can use to ensure they maximize their R&D dollars.
Defining improved efficiency
The use of 14C tracers – and ultra-low level analysis – is the future of effective drug development, says Michael J. Butler, Xceleron.
In line with in vivo
Taconic's Dr. Holger Kissel explains the significance of in vivo treatments, and tells NGP how researchers are providing efficient and reliable forms of study.
Pharmaceuticals and fertility
Rita Cortvrindt of EggCentris explains how reproductive functions can speed up the development of new drugs.
Source: www.ngpharma.eu.com© 2012 GDS Publishing Ltd. All rights reserved.